Behçet’s disease is a rare auto-immune condition that causes inflammation in blood vessels. This disease can cause a variety of symptoms that may not appear connected. Sores are the main ...

The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 2014;28:338-347.

Behçet's syndrome is an inflammatory disease involving articular, gastrointestinal, central nervous system, and peripheral vascular manifestations. In this Review, Dr Yazici and co-authors ...

--Soligenix, Inc., a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it ...

Phase 2a clinical study of SGX945 in Behçet's Disease initiating in 2024. PRINCETON, N.J., Feb. 8, 2024 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage ...

Data & APIs. Events. Premarket ...

New findings reveal phenotypic clusters in pediatric Behçet’s disease, offering insights into its variable presentation and highlighting the need for improved diagnostic awareness in children.

29 Oct - ANGERME member Yuki Hirayama recently revealed that she has been diagnosed with the rare disease called Behcet's disease. The news was shared by the singer on her blog on 25 October, saying ...

Behçet disease is a chronic multisystem inflammatory disorder with oral and genital ulcers present in up to 95% of patients. Skin manifestations are often papulopustular rashes or erythema ...

Behcet’s Disease Treatment Market Size By Type (Ocular-Behcet, Vasculo-Behcet, and Neuro-Behcet), By Route of Administration (Oral and Injectable), Regions, Segmentation, and forecast till ...

Dusquetide, the active ingredient in SGX945 (Behçet's Disease) and SGX942 (oral mucositis), is an innate defense regulator (IDR), a new class of short, synthetic peptides.It has a novel mechanism ...